HCM Projected Dividend Yield
ADR (Sponsored)/HUTCHMED (China) Ltd ( NASDAQ : HCM )HUTCHMED (China) is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of patients with cancer and immunological diseases. Co.'s Oncology/Immunology segment focuses on discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Co.'s Other Ventures segment comprises other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products. 20 YEAR PERFORMANCE RESULTS |
HCM Dividend History Detail HCM Dividend News HCM Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |